Skip to main content

Table 1 Possible factors affecting the efficacy of dapoxetine 30 mg treatment for 4 weeks

From: Efficacy of dapoxetine treatment in Chinese patients with premature ejaculation and possible factors affecting efficacy in the real-world practice

Parameters

CGIC-C

P

0 (n = 46)

≥1 (n = 108)

Age (yeas, mean ± SD)

33.8 ± 8.1

31.9 ± 6.1

0.213

Marital Status: Married

88.6%

84.5%

0.508

PE duration (years, mean ± SD)

6.4 ± 5.7

8.2 ± 6.8

0.058

Type of PE (% of primary PE)

84.8%

70.4%

0.060

Percentage of Intercourse frequency ≥ 2 times

43.4%

53.7%

0.245

Percentage of CP

41.3%

41.7%

0.967

Percentage of previous SSRI use

10.9%

18.5%

0.239

Percentage of previous Effective SSRI use

10.0%

28.6%

0.097

Percentage of history of Circumcision or penile dorsal nerve transection

28.3%

34.3%

0.467

PHQ-9(median [min, max])

6.0 [0, 27]

6.0 [0, 26]

0.835

GAD-7(median [min, max])

4.0 [0, 25]

3.5 [0, 21]

0.253

IELT (Seconds, mean ± SD)

56.3 ± 44.4

63.0 ± 42.5

0.262

NITBE (times, mean ± SD)

28.0 ± 22.0

41.5 ± 30.1

0.010*

PEDT (mean ± SD)

15.7 ± 2.7

14.5 ± 2.6

0.009*

  1. CGIC Clinical Global Impression of Change, CP chronic prostatitis, ED erectile dysfunction, GAD-7 General Anxiety Disorder Questionnaire, IELT intravaginal ejaculatory latency time, NITBE number of intravaginal thrusts before ejaculation, PE premature ejaculation, PEDT Premature Ejaculation Diagnostic Tool, PHQ-9 Patient Health Questionnaire-9 items, SD standard deviation, SSRI selective serotonin reuptake inhibitors
  2. *statistical significance